Coya Therapeutics Inc.

NASDAQ: COYA · Real-Time Price · USD
6.09
0.41 (7.12%)
At close: Aug 15, 2025, 3:59 PM
6.20
1.81%
After-hours: Aug 15, 2025, 07:54 PM EDT

Coya Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
423.45K 3.68M 3.55M 9.55M 9.55M 6.13M 6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
20.52K 13.68K 20.52K 20.52K 20.52K 27.36K 27.36K 27.36K 32.98K 26.14K 19.3K 22.64K 12.72K 12.72K 12.72K 2.53K n/a n/a
Gross Profit
402.93K 3.67M 3.53M 9.53M 9.53M 6.1M 5.97M -27.36K -32.98K -26.14K -19.3K -22.64K -12.72K -12.72K -12.72K -2.53K n/a n/a
Operating Income
-6.43B -19.44M -17.25M -11.35M -10.47M -10.49M -7.9M -11.72M -10.82M -11.01M -9.81M -9.41M -8.07M -5.6M -4.87M -3.27M -1.94M -970K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.11B -17.86M -15.6M -9.97M -9.38M -9.58M -7.26M -12.36M -12.96M -13.28M -12.24M -10.77M -8.08M -5.63M -4.89M -3.26M -1.93M -966K
Net Income
-6.11B -17.14M -14.88M -10.7M -10.1M -10.3M -7.82M -12.2M -12.8M -13.12M -12.25M -10.77M -8.08M -5.63M -4.89M -3.26M -1.93M -966K
Selling & General & Admin
2.92B 9.16M 8.89M 9.13M 8.87M 8.61M 7.83M 6.36M 5.63M 5.79M 4.85M 4.68M 3.99M 2.51M 2.31M 1.58M 1.04M 518.3K
Research & Development
3.67B 13.94M 11.87M 11.73M 11.1M 7.95M 6.04M 5.34M 5.16M 5.19M 4.94M 4.69M 4.07M 3.07M 2.54M 1.69M 900.97K 450.48K
Other Expenses
-6.56B 21K 14K 14.23K 15.23K 14.23K 21.07K 20.68K 53.1K 64.04K 61.23K 54.39K 14.97K 4.03K n/a n/a n/a n/a
Operating Expenses
23.04M 23.12M 20.77M 20.87M 19.98M 16.58M 13.91M 11.72M 10.82M 11.01M 9.81M 9.41M 8.07M 5.59M 4.86M 3.26M 1.93M 966.07K
Interest Expense
n/a n/a n/a 163.63K 163.63K 163.63K 163.63K 1.1M 1.1M 1.1M 1.11M 3.02K 3.02K 3.02K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
23.05M 23.13M 20.78M 20.88M 20M 16.59M 13.9M 11.72M 10.82M 11.01M 9.81M 9.41M 8.07M 5.6M 4.86M 3.26M 1.93M 966.07K
Income Tax Expense
-720.29K -720.29K -720.29K 723.85K 723.85K 723.85K 559.85K -164K -164K -186.34K -19.33K -19.33K -19.33K 3.02K n/a n/a n/a n/a
Shares Outstanding (Basic)
16.72M 16.72M 16.36M 15.22M 14.91M 14.46M 10.16M 9.95M 9.95M 9.95M 9.95M 9.68M 6.6M 6.6M 6.6M 9.68M 2.59M 2.59M
Shares Outstanding (Diluted)
16.72M 16.72M 16.36M 15.22M 14.91M 14.46M 10.16M 9.95M 9.95M 9.95M 9.95M 9.68M 6.6M 6.6M 6.6M 9.68M 2.59M 2.59M
EPS (Basic)
-1.24 -1.07 -0.98 -0.68 -0.76 -0.88 -0.79 -1.33 -1.41 -1.62 -1.62 -1.45 -1.17 -1.02 -1.13 -0.88 -0.74 -0.37
EPS (Diluted)
-1.24 -1.07 -0.98 -0.68 -0.76 -0.88 -0.79 -1.33 -1.41 -1.62 -1.62 -1.45 -1.17 -1.02 -1.13 -0.88 -0.74 -0.37
EBITDA
-6.43B -19.41M -17.22M -11.33M -10.44M -10.46M -7.88M -11.7M -10.79M -10.98M -9.78M -9.4M -8.08M -5.6M -4.88M -3.27M -1.94M -969K
EBIT
-22.3M -19.44M -17.22M -11.33M -10.44M -10.46M -7.9M -11.72M -10.69M -10.88M -9.68M -9.29M -8.1M -5.62M -4.89M -3.27M -1.94M -970K
Depreciation & Amortization
27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 32.98K 30.17K 27.36K 30.71K 20.78K 18.46K 16.13K 5.95K 3.42K 1.71K